The Goldman Sachs Group Cuts Abbott Laboratories (NYSE:ABT) Price Target to $140.00
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target cut by equities researchers at The Goldman Sachs Group from $152.00 to $140.00 in a research report issued to clients and investors on Friday,MarketScreener reports. The brokerage presently has a “buy” rating on the healthcare product maker’s stock. The Goldman Sachs Group’s target price […]
23 Jan 17:28 · The Markets Daily